Skip to main content
main-content

Cardiology

Latest articles

19-04-2017 | Rheumatology | News | Article

Celecoxib linked to reduced GI bleeding risk in patients with arthritis, cardiothrombotic disease

Results of the CONCERN trial suggest that celecoxib is associated with a lower risk for recurrent upper gastrointestinal bleeding than naproxen among patients with arthritis and cardiothrombotic diseases treated concomitantly with aspirin and non-steroidal anti-inflammatory drugs.

Source:

Lancet 2017; Advance online publication

07-03-2017 | Public health | Highlight | Article

Editor's pick

Diet associated with ‘substantial proportion’ of cardiometabolic deaths

Research published in JAMA suggests that suboptimal intake of specific dietary factors is associated with almost half of deaths from heart disease, stroke, or type 2 diabetes in the USA.

Source:

JAMA 2017; 317: 908–909, 912–924

06-03-2017 | Pulmonary hypertension | News | Article

Systemic sclerosis associated with poor survival in CTD-PAH

A Chinese cohort study identifies factors associated with prognosis among patients with connective tissue disease-associated pulmonary arterial hypertension.

Source:

Int J Cardiol 2017; Advance online publication

03-03-2017 | Interventional cardiology | News | Article

Editor's pick

No benefit of ischemic postconditioning during PCI

Results of the DANAMI-3–iPOST trial suggest that ischemic postconditioning during percutaneous coronary intervention does not improve clinical outcome for patients with ST-segment elevation myocardial infarction.

Source:

JAMA Cardiol 2017; Advance online publication

03-03-2017 | Pulmonary hypertension | News | Article

Right atrial strain associated with clinical outcomes in PAH

Study results suggest that right atrial strain could predict adverse outcomes among patients with pulmonary arterial hypertension.

Source:

Int J Cardiovasc Imaging 2017; Advance online publication

02-03-2017 | Interventional cardiology | News | Article

Benefits of complete versus target-only revascularization examined in multivessel CAD

Results of a meta-analysis suggest that complete revascularization is associated with a reduced risk for cardiac events, but not overall mortality, among patients with ST-segment elevation myocardial infarction and multivessel coronary artery disease.

Source:

JACC Cardiovasc Interv 2017; 10: 315–324, 325–328

01-03-2017 | Arrhythmia | News | Article

No reduction in AF recurrence with aggressive blood pressure treatment

Reducing target blood pressure does not decrease the incidence of recurrent arrhythmia among patients undergoing catheter ablation for atrial fibrillation, results of a randomized trial suggest.

Source:

Circulation 2017; Advance online publication

24-02-2017 | Cardiology | News | Article

No reduction in intraoperative bleeding with fibrinogen concentrate

Results of a randomized trial published in JAMA suggest that infusion of fibrinogen concentrate does not reduce intraoperative blood loss during high-risk cardiac surgery.

Source:

JAMA 2017; 317: 738–747

23-02-2017 | Cardiology | News | Article

News in brief

Mediterranean diet may improve HDL atheroprotective functions

Adherence to a traditional Mediterranean diet could improve the atheroprotective functions of high-density lipoprotein among people with high cardiovascular risk, results from a substudy of the PREDIMED trial suggest.

21-02-2017 | Interventional cardiology | News | Article

Transradial CTO PCI may be feasible for noncomplex cases

Transradial percutaneous coronary intervention could be feasible for the treatment of noncomplex chronic total occlusions, but complex cases may require a transfemoral approach, Japanese researchers report.

Source:

JACC Cardiovasc Interv 2017; 10: 235–243, 244–246

17-02-2017 | Interventional cardiology | News | Article

Similar outcomes with BMS and DES in myocardial infarction with cardiogenic shock

Study results suggest that patients with acute myocardial infarction complicated by cardiogenic shock have similar outcomes when treated with drug-eluting or bare metal stents.

Source:

Heart 2017; Advance online publication

16-02-2017 | Arrhythmia | Main feed | Article

Real-world effectiveness, safety of novel oral anticoagulants in AF explored

A Danish nationwide cohort study published in The BMJ examines the effectiveness and safety profiles of novel oral anticoagulants among patients with atrial fibrillation.

Source:

BMJ 2017; 356: j510

15-02-2017 | Heart failure | News | Article

Elevated hs-cTnT levels could indicate subclinical cardiac disease

Minor increases in high-sensitivity cardiac troponin T levels may represent an early biochemical signature of subclinical heart disease, researchers report.

Source:

Circulation 2017; Advance online publication

13-02-2017 | Hypertension | News | Article

Quarter-dose quadpill a promising antihypertensive approach

A pilot randomized crossover trial suggests that giving patients a single pill composed of four antihypertensives at a quarter of their usual dose is a promising means of controlling blood pressure.

Source:

Lancet 2017; Advance online publication

10-02-2017 | Interventional cardiology | Highlight | Article

Editor's pick

Steady long-term risk of late events with first-generation DES

Patients with first-generation drug-eluting coronary stents remain at risk for late adverse events, say researchers who report the 10-year outcomes of the Danish all-comer SORT OUT II trial.

Source:

J Am Coll Cardiol 2017; 69: 616–624, 625–627

08-02-2017 | Stroke | Highlight | Article

Prolonged ECG monitoring improves post-stroke atrial fibrillation detection

Research suggests that all patients aged 60 years or older who have had a stroke, irrespective of the suspected cause, could benefit from enhanced and prolonged monitoring for atrial fibrillation.

Source:

Lancet Neurol 2017; Advance online publication

06-02-2017 | Interventional cardiology | News | Article

Health benefits of TAVR extend beyond the trial setting

Study results suggest that the health status benefits of transcatheter aortic valve replacement that have been observed in clinical trials extend to real-world clinical practice.

Source:

JAMA Cardiol 2017; Advance online publication

01-02-2017 | Interventional cardiology | News | Article

Editor's pick

Meta-analysis raises further concerns about bioresorbable scaffolds

The results of a meta-analysis add to evidence suggesting that bioresorbable vascular scaffolds are associated with unfavorable clinical outcomes compared with drug-eluting stents among patients with coronary artery disease.

Source:

Heart 2017; Advance online publication

31-01-2017 | Interventional cardiology | News | Article

No benefit of routine follow-up angiography after PCI

Results of the ReACT trial suggest no additional benefit with follow-up coronary angiography after percutaneous coronary intervention in daily clinical practice.

Source:

JACC Cardiovasc Interv 2017; 10: 109–117, 118–120

27-01-2017 | Cardiology | News | Article

Globorisk expands CVD risk estimates to 182 countries

The Globorisk project has published charts for the cardiovascular disease risk assessment of people in 182 countries.

Source:

Lancet Diabetes Endocrinol 2017; Advance online publication

image credits